Immunoassays for anti-SARS-CoV-2 antibodies: recent insights.

Van Elslande, Jan; André, Emmanuel; Van Ranst, Marc; Lagrou, Katrien; Vermeersch, Pieter

Van Elslande, Jan; André, Emmanuel; Van Ranst, Marc; Lagrou, Katrien; Vermeersch, Pieter.

Van Elslande J; Clinical Department of Laboratory Medicine and National Reference Centre for Respiratory Pathogens, University Hospitals Leuven, 3000 Leuven, Belgium.
André E; Clinical Department of Laboratory Medicine and National Reference Centre for Respiratory Pathogens, University Hospitals Leuven, 3000 Leuven, Belgium; Department of Microbiology, Immunology and Transplantation, KU Leuven, Leuven, Belgium.
Van Ranst M; Clinical Department of Laboratory Medicine and National Reference Centre for Respiratory Pathogens, University Hospitals Leuven, 3000 Leuven, Belgium; Department of Microbiology, Immunology and Transplantation, KU Leuven, Leuven, Belgium.
Lagrou K; Clinical Department of Laboratory Medicine and National Reference Centre for Respiratory Pathogens, University Hospitals Leuven, 3000 Leuven, Belgium; Department of Microbiology, Immunology and Transplantation, KU Leuven, Leuven, Belgium.
Vermeersch P; Clinical Department of Laboratory Medicine and National Reference Centre for Respiratory Pathogens, University Hospitals Leuven, 3000 Leuven, Belgium; Department of Cardiovascular Sciences, KU Leuven, Leuven, Belgium. Electronic address: pieter.vermeersch@uzleuven.be.

Lancet Infect Dis ; 21(5): e120, 2021 05.

Article in English | MEDLINE | ID: covidwho-1510466

Subject(s)

COVID-19; SARS-CoV-2; Antibodies, Viral; Benchmarking; Humans; Immunoassay

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: SARS-CoV-2 / COVID-19 Limits: Humans Language: English Journal: Lancet Infect Dis Journal subject: Communicable Diseases Year: 2021 Document Type: Article Affiliation country: S1473-3099(20)30846-x

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google